Digital Tool Potentially Predicts Childhood Asthma
By Dennis Thompson HealthDay Reporter

TUESDAY, June 17, 2025 — A new digital tool can flag kids who are at risk for developing childhood asthma, researchers report.
The tool scans electronic health data records and calculates an asthma risk score for children, according to results published recently in eClinical Medicine.
It relies on information that’s routinely collected as part of kids’ medical history, researchers said.
"Our hope is that using the childhood asthma passive digital marker in clinical practice will improve the early detection of asthma risk in high-risk children, allowing for earlier interventions that could improve asthma control and lessen the future risk of hospitalization," lead researcher Arthur Owora, an associate professor of pediatrics at the Indiana University School of Medicine, said in a news release.
For the study, researchers used the tool to comb through records of more than 69,000 Indiana children born between 2010 and 2017, of whom just under 8% had been diagnosed with asthma after age four.
The digital tool was better able to predict which kids at age 3 had a higher risk of developing childhood asthma, results show.
The tool predicted asthma among 37% of those children, versus 26% using an earlier pediatric asthma risk score, researchers found.
Results suggest pneumonia and bronchiolitis are two of the most powerful predictors for childhood asthma, the study says.
The new tool could be an easily adopted means of helping doctors detect children at high risk for asthma, researchers concluded.
"This passive digital marker is very scalable because it requires zero additional minutes from the clinical team by using the already captured data in the electronic health record," senior researcher Dr. Malaz Boustani, director of the IU Center for Health Innovation and Implementation Science, said in a news release.
Prompt diagnosis of asthma can help parents and kids better avoid asthma triggers and improve use of asthma inhalers, researchers said.
"Scalable innovations like this in pediatrics have unbelievable public health impact for the health of the future generation of Americans,” Boustani added.
The team next plans to test the tool using a randomized clinical trial, to see if it actually increases early diagnoses among children at high risk of asthma.
"If the trial is successful, we will explore scaling up the implementation to ensure the benefits of early detection are realized at the state and hopefully at the national level as well," Owora said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-18 00:00
Read more

- Weed Use Linked To Heart-Related Deaths
- Chicken Alfredo Meals Recalled After Listeria Outbreak Kills 3
- FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo
- Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug
- Higher Dose of Wegovy Provided Average Weight Loss of 21% in People with Obesity With a Third Achieving 25% or More
- Generative AI Model for Draft Radiological Reporting Improves Documentation Efficiency
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions